STUDY ON THE RATE AND RISK FACTORS OF RECURRENT ISCHEMIC STROKE AT CAN THO CENTRAL GENERAL HOSPITAL
Main Article Content
Abstract
Background: Recurrent ischemic stroke (RIS) is a severe event that significantly increases the risk of mortality and disability. Identifying its rate and related factors is essential to improve treatment outcomes and secondary prevention. Objective: To determine the rate, etiological classification, and risk factors associated with recurrent ischemic stroke within 12 months after the first episode among patients treated at Can Tho Central General Hospital during the period 2022–2024. Methods: A prospective cohort study was conducted on 890 patients with ischemic stroke, each followed up for at least 12 months. Results: The 12-month recurrence rate was 6.7%. The cumulative recurrence rates were 2% at 1 month, 3.6% at 6 months, and 6.7% at 12 months. According to the TOAST classification, recurrence was most frequent in the large-artery atherosclerosis (LAA) group (38.2%) and cardioembolic (CE) group (24.7%), and least common in small-vessel disease (SVD) (21.3%). Cox regression analysis identified independent risk factors, including age ≥65 years, hypertension, diabetes mellitus and discontinuation of anticoagulant or antiplatelet therapy. Conclusion: The recurrence rate of ischemic stroke at Can Tho Central General Hospital (6.7%) was comparable to international data (5–7%). The highest recurrence risk was observed in the LAA and CE subtypes, particularly among patients who discontinued anticoagulant or antiplatelet therapy.
Article Details
Keywords
Recurrent ischemic stroke, etiology, related factors, Can Tho.
References
2. Hankey GJ. Secondary stroke prevention. Lancet Neurol. 2014;13(2):178–194.
3. Kolmos M, Christoffersen L, Kruuse C. Recurrent ischemic stroke: A systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2021;30(12):106098.
4. Powers WJ, Rabinstein AA, Ackerson T, et al. 2021 AHA/ASA Guideline for the Prevention of Stroke in Patients With Stroke and TIA. Stroke. 2021;52:e364–e467.
5. Amarenco P, Lavallée PC, Labreuche J, et al. One-year risk of stroke after transient ischemic attack or minor stroke. N Engl J Med. 2016;374:1533–1542.
6. Wang Y, Li Z, Zhao X, et al. China Stroke Surveillance Report 2021. Beijing: National Health Commission; 2022.
7. Hata J, Tanizaki Y, Kiyohara Y, et al. Ten-year recurrence after first-ever stroke in a Japanese community: The Hisayama Study. J Neurol Neurosurg Psychiatry. 2005;76:368–372.
8. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke: TOAST. Stroke. 1993;24(1):35–41.
9. Li Z, Wang C, Zhao X, et al. Recurrence after ischemic stroke in the Chinese National Stroke Registry (CNSR). Stroke. 2015;46:2719–2724.
10. Pan Y, Chen W, Amarenco P, et al. Prevalence and impact of medication discontinuation after ischemic stroke in China. Stroke. 2020;51:365–373.